New research presented this week at the European League Against Rheumatism annual meeting in Paris outlines a new and more accurate method of assessing risk for heart disease in patients with rheumatoid arthritis. Rheumatoid arthritis patients are twice as likely as the average person to develop heart problems, and identifying those at risk had been problematic with existing assessment tools.
The new risk calculator, Transatlantic Cardiovascular Risk Calculator for Rheumatoid Arthritis, or ATACC-RA, was demonstrated to be more effective for rheumatoid arthritis patients than standard heart disease risk calculators such as the Framingham and SCORE risk assessment tools. The international research team plans further work to test and refine the calculator so it can be personalized for patients.
Read a news report about the findings here.
View related content here.